When patients fail to take their medicine as
prescribed, the financial impact on the pharmaceutical industry is substantial.
Even more distressing is the damage that is done to a patient's health and well
Both the financial and social implications of non-compliance were the
subjects of the recent 7th Annual Forum
on Patient Compliance, Adherence and Persistency
held in Philadelphia.
This article presents highlights from this forum and discusses several issues, including:
does Adherence Mean?
Can't Control What You Don't Measure
- Do We Really Know What It Costs?
- Business Case: Vaccine/Text Messaging
- Walgreens' Approach
- Invasive Compliance: A Bitter Pill to Swallow
- Winners of the Third Annual Strategic Patient Adherence (SPA) Awards
Read this article now. It's FREE...
Download PDF file